Lista de obras - Cristina Zuccato - Dominio Público Uruguay

A Novel Frameshift Mutation (+A) at Codon 18 of the β-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and δβ-Thalassemia

article

A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs

artículo científico publicado en 2022

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction

artículo científico publicado en 2012

Bergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.

artículo científico publicado en 2009

Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia ⬇️

artículo científico publicado el 1 de junio de 2013

Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations

artículo científico publicado en 2009

Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives.

artículo científico publicado en 2009

Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients

artículo científico publicado en 2006

Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives

artículo científico publicado en 2006

Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β<sup>0</sup>39-thalassemia patients

artículo científico publicado en 2021

Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin

artículo científico publicado en 2015

Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.

artículo científico publicado en 2010

Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells

artículo científico publicado en 2006

Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

scientific article published on 11 December 2007

Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.

artículo científico publicado en 2015

Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs

artículo científico publicado en 2009

Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells

artículo científico publicado en 2015

Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts

artículo científico publicado en 2013

Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives.

artículo científico publicado en 2007

Involvement of miRNA in erythroid differentiation

artículo científico

Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations

Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters.

artículo científico publicado en 2006

Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients

artículo científico publicado en 2009

Recent trends in the gene therapy of β-thalassemia

artículo científico publicado en 2015

Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients

artículo científico publicado en 2012

Structure and Biological Activity of Furocoumarins

Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives

artículo científico publicado en 2010

Tobramycin is a suppressor of premature termination codons

artículo científico publicado en 2013

Lista de obras de Cristina Zuccato

A Novel Frameshift Mutation (+A) at Codon 18 of the β-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and δβ-Thalassemia

A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction

Bergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.

Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia ⬇️

Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations

Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives.

Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients

Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives

Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β<sup>0</sup>39-thalassemia patients

Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin

Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.

Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells

Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.

Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs

Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells

Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts

Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives.

Involvement of miRNA in erythroid differentiation

Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations

Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters.

Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients

Recent trends in the gene therapy of β-thalassemia

Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients

Structure and Biological Activity of Furocoumarins

Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives

Tobramycin is a suppressor of premature termination codons